Metodological aspects of development of gels for treating inflammatory dental diseases

Abstract

Inflammatory periodontal diseases take one of the first places among dental diseases; they are prevalent in various age groups and tend to grow steadily. The highest morbidity rate is found at the age from 15 to 44, that is 64-98% of the population. For the rational pathogenetic therapy, multiagent medications affecting different parts of the pathological process in a multiple way should be developed.